Bicillin L-A recalled over manufacturing violations

Recall date

July 10, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Pfizer Inc. recalls Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed…

Recall number

D-0545-2025

FDA classification

Class II

Brand / firm

Pfizer Inc.

Sold / distributed

Nationwide in the USA

Why it was recalled

CGMP Deviations; particulates identified during visual inspection

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04